The FDA approves Spravato, a nasal spray derived from Ketamine, to help some people treat depression. Dr. Bill Hartman from UW Health shares more.

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral antidepressants. On Tuesday, the Food and Drug Administration (FDA) ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...

I was 17, shopping for prom dresses, and ordering my cap and gown for high school graduation when the world abruptly shut ...

A man who admits being addicted to the so-called party drug Ketamine says it has had a devastating impact on his life, leaving him needing bladder surgery. George is among a number of young people ...

Kadima offers ketamine therapy, the prescription nasal spray medication Spravato and transcranial magnetic stimulation – a non-invasive treatment that uses magnetic pulses to stimulate specific ...

The death of a 2-month-old Queens boy 16 months ago has been deemed a homicide after it was determined the tot died from a ketamine overdose, police said Wednesday. Little Mike Nieto Parra was ...

There was no effect of insulin in the larger cohort using the second device. In a subsequent Phase 2 study to determine how much insulin entered the brain after nasal delivery, 19 people received 40 ...

Health insurance rules capping monthly out-of-pocket costs for insulin, asthma inhalers, and epinephrine injectors took effect on New Year’s Day. The provisions, required under a law Gov. Phil Murphy ...